Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-10-005167
Filing Date
2010-02-05
Accepted
2010-02-05 15:59:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a10-2970_3sc13ga.htm SC 13G/A 65581
  Complete submission text file 0001104659-10-005167.txt   67617
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-51477 | Film No.: 10577444
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 890 WINTER STREET WALTHAM MA 02451
Business Address 890 WINTER STREET WALTHAM MA 02451 7816221700
Atlas Venture Fund VII L P (Filed by) CIK: 0001346450 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: SC 13G/A